Press Conference Wednesday, October 10th

Press Conference
Wednesday, October 10th

Jeanne Henry
Director Office of Public Affairs
State of Missouri, Department of Mental Health

The last day of the conference the Missouri Department of Mental Health’s Office of Public Affairs interviewed many of the luminaries attending the conference. Included in the interviews were Joycelyn Woods, Howard Lotsof and Barbara Finger.

The interviews will be broadcast in the Midwest and gave patient advocates the opportunity to reach out to many in rural areas and discuss the effectiveness of methadone treatment.

Barbara Finger is interviewed about how methadone has helped her live a normal life and her decision to be an advocate.

Sponsored by State of Missouri, Department of Mental Health

Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director

Similar Posts

  • The National Methadone Conference-2

    Admin 04/26/2021

    Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session A Day of Methadone Advocacy Training NAMA Moves Methadone Advocacy to a New Level with training and certification. Includes a Photo Album of the Day and Jo L. Sotheran’s presentation on Working a…

  • A Tour of BrugerForeningen

    Admin 11/27/2021

    Drop In Room (hyggekrog) The Drop In Room provides a Cosy Corner for users and members to meet and relax. Dining Table (spisebord_og_buffet) The other end of the bright airy room has a dining table that seats up to 16 persons for buffets and informal luncheons. Full Equiped Kitchen (storkkkenet) A large kitchen is attached…

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Tag: discrimination

    Admin 04/17/2021

    Justice Department Finds that Indiana State Nursing Board Discriminates Against People with Opioid Use Disorder March 30, 2022 FOR IMMEDIATE RELEASE Friday, March 25, 2022 Indianapolis – Today, the Justice Department found that the Indiana State Board of Nursing (Nursing Board) violated the Americans with Disabilities Act (Ada) by prohibiting nurses who take medication to…

  • A Personal Report to NAMA’s Chapters and Affiliates

    Admin 02/05/2022

    On the Invitational Conference on Drug User Activism Sponsored by the Danish Drug Users Union (BrugerForeningen) and Dutch National Interest Group of Drug Users (Landelijk Steunpunt Druggebruikers 2003, October 31st/November 1st Copenhagen, Denmark Howard S. Lotsof Board of Directors NAMA President, Dora Weiner Foundation http://www.doraweiner.org Submitted 27 November 2003 I came to be informed of…